1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR

mTOR (哺乳动物雷帕霉素靶蛋白)

Mammalian target of Rapamycin

mTOR(哺乳动物雷帕霉素靶蛋白)是一种由人类 mTOR 基因编码的蛋白质。mTOR 是一种丝氨酸/苏氨酸蛋白激酶,可调节细胞生长、细胞增殖、细胞运动、细胞存活、蛋白质合成和转录。mTOR 属于磷脂酰肌醇 3-激酶相关激酶蛋白家族。mTOR 整合上游通路的输入,包括生长因子和氨基酸。mTOR 还能感知细胞营养、氧气和能量水平。mTOR 通路在人类疾病中失调,例如糖尿病、肥胖症、抑郁症和某些癌症。雷帕霉素通过与其细胞内受体 FKBP12 结合来抑制 mTOR。FKBP12-雷帕霉素复合物直接与 mTOR 的 FKBP12-雷帕霉素结合 (FRB) 域结合,从而抑制其活性。

mTOR (mammalian target of Rapamycin) is a protein that in humans is encoded by the mTOR gene. mTOR is a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. mTOR belongs to the phosphatidylinositol 3-kinase-related kinase protein family. mTOR integrates the input from upstream pathways, including growth factors and amino acids. mTOR also senses cellular nutrient, oxygen, and energy levels. The mTOR pathway is dysregulated in human diseases, such as diabetes, obesity, depression, and certain cancers. Rapamycin inhibits mTOR by associating with its intracellular receptor FKBP12. The FKBP12-rapamycin complex binds directly to the FKBP12-Rapamycin Binding (FRB) domain of mTOR, inhibiting its activity.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-162024
    mTOR inhibitor-16 Inhibitor
    mTOR inhibitor-16 (Compound 9f) 是 mTOR 的选择性抑制剂。mTOR inhibitor-10 抑制 mTORPI3K-αIC50 分别为 1.25 和 82 nM。mTOR inhibitor-10 抑制 LNCaP 细胞增殖,IC50 为 140 nM。
    mTOR inhibitor-16
  • HY-13246R
    Apitolisib (Standard) Inhibitor
    Apitolisib (Standard) 是 Apitolisib 的分析标准品。本产品用于研究及分析应用。Apitolisib (GDC-0980; GNE 390; RG 7422) 是一种口服有效的 PI3KmTOR (TORC1/2) 激酶抑制剂,抑制 PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ 的活性,IC50 值为 5 nM/27 nM/7 nM/14 nM。 抑制mTORKi 为 17 nM。
    Apitolisib (Standard)
  • HY-116191
    WJD008 Inhibitor
    WJD008 是一种强效的双重磷脂酰肌醇 3-激酶 (PI3K)/哺乳动物雷帕霉素靶点 (mTOR) 抑制剂,对肿瘤细胞和带有 PIK3CA 突变的转化细胞表现出抗增殖和抗克隆生成的作用。WJD008 抑制 PI3K αmTOR 的激酶活性,并消除了类胰岛素生长因子-I 激活的 PI3K-Akt-mTOR 信号通路。WJD008 有望用于癌症的研究。
    WJD008
  • HY-164662
    mTOR inhibitor-24 Inhibitor
    mTOR inhibiter-24 (comounp 9d) 是一种 mTOR 抑制剂,IC50 分别为 0.34 nM (mTOR) 和 324 nM (PI3K-α)。mTOR inhibiter-24 抑制 LNCaP 细胞增殖 (IC50: 180 nM)。
    mTOR inhibitor-24
  • HY-155475
    mTORC1-IN-2 Inhibitor
    mTORC1-IN-2 (compound H3) 是 NO 供体化合物,可缓解血管扩张和减轻心肌缺氧损伤。mTORC1-IN-2 可上调 TSC2-P 表达,并抑制 mTORC1 表达。
    mTORC1-IN-2
  • HY-10681R
    Gedatolisib (Standard) Inhibitor
    Gedatolisib (Standard) 是 Gedatolisib 的分析标准品。本产品用于研究及分析应用。Gedatolisib (PKI-587) 是一种高效的双重 PI3KαPI3KγmTOR 抑制剂, IC50 分别为 0.4 nM,5.4 nM 和 1.6 nM。Gedatolisib 在 mTOR 复合物 mTORC1mTORC2 中同样有效。
    Gedatolisib (Standard)
  • HY-10115R
    PI-103 (Standard) Inhibitor
    PI-103 (Standard)是 PI-103 的分析标准品。本产品用于研究及分析应用。PI-103 是一种有效的 PI3K mTOR 抑制剂,抑制 p110αp110βp110δp110γmTORC1mTORC2IC50 分别为 8 nM,88 nM,48 nM,150 nM,20 nM 和 83 nM。PI-103 还抑制 DNA-PK,IC50 为 2 nM。PI-103 诱导自噬 (autophagy)
    PI-103 (Standard)
  • HY-112903A
    YW3-56 hydrochloride Inhibitor
    YW3-56 (hydrochloride) 是一种 PAD 抑制剂。YW3-56 (hydrochloride) 可激活 p53 靶基因。YW3-56 (hydrochloride) 可激活 ATF 并阻断 autophagy flux。YW3-56 (hydrochloride) 通过 PERK-eIF2α-ATF4 信号级联诱导 ER 应激,并抑制 mTOR 信号。YW3-56 (hydrochloride) 对三阴性乳腺癌有抑制作用。
    YW3-56 hydrochloride
  • HY-13691R
    MKC-1 (Standard) Inhibitor
    MKC-1 (Standard) 是 MKC-1 的分析标准品。本产品用于研究及分析应用。MKC-1 (Ro-31-7453) 是一种口服有效的细胞周期抑制剂,具有广泛的抗肿瘤活性。MKC-1 抑制 Akt/mTOR 通路。通过结合一系列不同的细胞蛋白,包括微管蛋白 (tubulin) 和导入蛋白 β (importin β) 家族成员,MKC-1 阻止细胞有丝分裂并诱导细胞凋亡 (apoptosis)[2]
    MKC-1 (Standard)
  • HY-14581R
    Palomid 529 (Standard) Inhibitor
    Palomid 529 (Standard) 是 Palomid 529 的分析标准品。本产品用于研究及分析应用。Palomid 529 是一种有效的 mTORC1mTORC2 复合体抑制剂。
    Palomid 529 (Standard)
  • HY-117923
    PF-06465603 Inhibitor
    PF-06465603 是一种高度有效且选择性的 ATP 竞争性激酶抑制剂,是 1 类 PI3KmTOR 抑制剂。PF-06465603 是 PF-04691502 的代谢产物,具有末端羧酸结构。
    PF-06465603
  • HY-50673A
    Dactolisib hydrochloride Inhibitor
    Dactolisib (BEZ235) hydrochloride 是一种具有口服活性的、双重的 pan-class I PI3KmTOR 抑制剂,作用于 p110α/γ/δ/βmTORIC50 分别为 4 nM/5 nM/7 nM/75 nM 和 20.7 nM。Dactolisib hydrochloride (BEZ235) 抑制 mTORC1mTORC2
    Dactolisib hydrochloride
  • HY-W419331
    Methionyl-methionine Activator
    Methionylmethionine (Met-Met) 通过增强细胞内底物的可用性以及激活 JAK2-STAT5 和 mTOR 介导的信号通路,显著促进了乳腺外植体中 α-s1 酪蛋白 (αS1-CN) 的表达。
    Methionyl-methionine
  • HY-13328R
    Sapanisertib (Standard)

    沙帕色替 (Standard)

    Inhibitor
    Sapanisertib (Standard) 是 Sapanisertib 的分析标准品。本产品用于研究及分析应用。Sapanisertib (INK-128; MLN0128; TAK-228) 是一种口服有效的 ATP依赖性的 mTOR1/2 抑制剂,抑制 mTOR 激酶的IC50 值为 1 nM。
    Sapanisertib (Standard)
  • HY-W779800
    D-α-Hydroxyglutaric acid-13C5 disodium Inhibitor
    D-α-Hydroxyglutaric acid-13C5 disodium 是 13C 标记的 D-α-Hydroxyglutaric acid (HY-113038)。稳定或放射性同位素标记的化合物可用于代谢分析,使得单个原子的动向能够被精准追踪和量化。
    D-α-Hydroxyglutaric acid-<sup>13</sup>C<sub>5</sub> disodium
  • HY-N0112S
    Dihydromyricetin-d4

    二氢杨梅素-d4 ; 白蔹素-d4

    Inhibitor
    Dihydromyricetin-d4 (Ampelopsin-d4) 是氘代标记的 Dihydromyricetin. Dihydromyricetin 是一种有效的二氢嘧啶酶 (dihydropyrimidinase) 抑制剂,IC50 为 48 μM。Dihydromyricetin 可通过抑制 mTOR 信号从而激活自噬。Dihydromyricetin 抑制 mTOR 复合体 (mTORC1/2) 形成。Dihydromyricetin 还是一种流感依赖 RNA 的 RNA 聚合酶抑制剂,IC50 为 22 μM。
    Dihydromyricetin-d<sub>4</sub>
  • HY-162025
    mTOR inhibitor-17 Inhibitor
    mTOR inhibitor-17 (Compound 9e) 是 mTOR 的选择性抑制剂。mTOR inhibitor-10 抑制 mTORPI3K-αIC50 分别为 0.68 和 1359 nM。mTOR inhibitor-10 抑制 LNCaP 细胞增殖,IC50 为 40 nM。
    mTOR inhibitor-17
  • HY-10115AR
    PI-103 Hydrochloride (Standard) Inhibitor
    PI-103 (Hydrochloride) (Standard)是 PI-103 (Hydrochloride) 的分析标准品。本产品用于研究及分析应用。PI-103 Hydrochloride 是一种有效的 PI3K mTOR 抑制剂,抑制 p110αp110βp110δp110γmTORC1mTORC2IC50 分别为 8 nM,88 nM,48 nM,150 nM,20 nM 和 83 nM。PI-103 Hydrochloride 也可抑制DNA-PK,IC50 为 2 nM。PI-103 Hydrochloride 诱导自噬 (autophagy)
    PI-103 Hydrochloride (Standard)
  • HY-B0627R
    Metformin (Standard)

    二甲双胍 (Standard)

    Inhibitor
    Metformin (Standard) 是 Metformin 的分析标准品。本产品用于研究及分析应用。Metformin (1,1-Dimethylbiguanide) 抑制肝脏中的线粒体呼吸链,导致 AMPK 活化,增强胰岛素敏感性,可用于 2 型糖尿病的研究。Metformin 也抑制肝脏缺血/再灌注损伤引起的肝脏氧化应激、亚硝化应激、炎症和细胞凋亡 (apoptosis)。此外,Metformin 还通过激活 AMPK 和抑制 mTOR
    Metformin (Standard)
  • HY-128932R
    Cefminox sodium (Standard)

    头孢米诺钠(Standard)

    Cefminox (sodium) (MT-141) (Standard)是 Cefminox (sodium) 的分析标准品。本产品用于研究及分析应用。Cefminox sodium 是一种半合成头霉素,具有抗菌活性。Cefminox sodium 是一种广谱杀菌头孢菌素类抗生素。Cefminox sodium 还可作为前列环素受体 (IP) 和 PPARγ 的双重激动剂。Cefminox sodium 可上调 cAMP 的产生和 PTEN 的表达,并抑制 Akt/mTOR 信号传导。Cefminox sodium 还可预防大鼠模型中的肺动脉高压。
    Cefminox sodium (Standard)
目录号 产品名 / 同用名 应用 反应物种

The mammalian target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of cell metabolism, growth, proliferation and survival[1]. mTOR is the catalytic subunit of two distinct complexes called mTORC1 and mTORC2. mTORC1 comprises DEPTOR, PRAS40, RAPTOR, mLST8, mTOR, whereas mTORC2 comprises DEPTOR, mLST8, PROTOR, RICTOR, mSIN1, mTOR[2]. Rapamycin binds to FKBP12 and inhibits mTORC1 by disrupting the interaction between mTOR and RAPTOR. mTORC1 negatively regulates autophagy through multiple inputs, including inhibitory phosphorylation of ULK1 and TFEB. mTORC1 promotes protein synthesis through activation of the translation initiation promoter S6K and through inhibition of the inhibitory mRNA cap binding 4E-BP1, and regulates glycolysis through HIF-1α. It promotes de novo lipid synthesis through the SREBP transcription factors. mTORC2 inhibits FOXO1,3 through SGK and Akt, which can lead to increased longevity. The complex also regulates actin cytoskeleton assembly through PKC and Rho kinase[3]

 

Growth factors: Growth factors can signal to mTORC1 through both PI3K-Akt and Ras-Raf-MEK-ERK axis. For example, ERK and RSK phosphorylate TSC2, and inhibit it.

 

Insulin Receptor: The activated insulin receptor recruits intracellular adaptor protein IRS1. Phosphorylation of these proteins on tyrosine residues by the insulin receptor initiates the recruitment and activation of PI3K. PIP3 acts as a second messenger which promotes the phosphorylation of Akt and triggers the Akt-dependent multisite phosphorylation of TSC2. TSC is a heterotrimeric complex comprised of TSC1, TSC2, and TBC1D7, and functions as a GTPase activating protein (GAP) for the small GTPase Rheb, which directly binds and activates mTORC1. mTORC2 primarily functions as an effector of insulin/PI3K signaling. 

 

Wnt: The Wnt pathway activates mTORC1. Glycogen synthase kinase 3β (GSK-3β) acts as a negative regulator of mTORC1 by phosphorylating TSC2. mTORC2 is activated by Wnt in a manner dependent on the small GTPase RAC1[4].

 

Amino acids: mTORC1 senses both lysosomal and cytosolic amino acids through distinct mechanisms. Amino acids induce the movement of mTORC1 to lysosomal membranes, where the Rag proteins reside. A complex named Ragulator, interact with the Rag GTPases, recruits them to lysosomes through a mechanism dependent on the lysosomal v-ATPase, and is essential for mTORC1 activation. In turn, lysosomal recruitment enables mTORC1 to interact with GTP-bound RHEB, the end point of growth factor. Cytosolic leucine and arginine signal to mTORC1 through a distinct pathway comprised of the GATOR1 and GATOR2 complexes.    

 

Stresses: mTORC1 responds to intracellular and environmental stresses that are incompatible with growth such as low ATP levels, hypoxia, or DNA damage. A reduction in cellular energy charge, for example during glucose deprivation, activates the stress responsive metabolic regulator AMPK, which inhibits mTORC1 both indirectly, through phosphorylation and activation of TSC2, as well as directly through the phosphorylation of RAPTOR. Sestrin1/2 are two transcriptional targets of p53 that are implicated in the DNA damage response, and they potently activate AMPK, thus mediating the p53-dependent suppression of mTOR activity upon DNA damage. During hypoxia, mitochondrial respiration is impaired, leading to low ATP levels and activation of AMPK. Hypoxia also affects mTORC1 in AMPK-independent ways by inducing the expression of REDD1, the protein products of which then suppress mTORC1 by promoting the assembly of TSC1-TSC2[2].

 

Reference:

[1]. Laplante M, et al.mTOR signaling at a glance.J Cell Sci. 2009 Oct 15;122(Pt 20):3589-94. 
[2]. Zoncu R, et al. mTOR: from growth signal integration to cancer, diabetes and ageing.Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. 
[3]. Johnson SC, et al. mTOR is a key modulator of ageing and age-related disease.Nature. 2013 Jan 17;493(7432):338-45.
[4]. Shimobayashi M, et al. Making new contacts: the mTOR network in metabolism and signalling crosstalk.Nat Rev Mol Cell Biol. 2014 Mar;15(3):155-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.